Hypertension Canada's 2016 Canadian Hypertension Education Program guidelines for pharmacists: An update.
作者信息
Al Hamarneh Yazid N, Houle Sherilyn K D, Padwal Raj, Tsuyuki Ross T
机构信息
EPICORE Centre/COMPRIS (Al Hamarneh, Tsuyuki) and the Department of Medicine (Al Hamarneh, Tsuyuki), University of Alberta, Edmonton, Alberta; and the University of Waterloo School of Pharmacy (Houle), Kitchener, Ontario.
出版信息
Can Pharm J (Ott). 2016 Nov;149(6):337-344. doi: 10.1177/1715163516671747. Epub 2016 Oct 6.
Abstract
摘要
相似文献
1
Hypertension Canada's 2016 Canadian Hypertension Education Program guidelines for pharmacists: An update.
Can Pharm J (Ott). 2016 Nov;149(6):337-344. doi: 10.1177/1715163516671747. Epub 2016 Oct 6.
2
Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension.
Can J Cardiol. 2016 May;32(5):569-88. doi: 10.1016/j.cjca.2016.02.066. Epub 2016 Mar 10.
3
Hypertension Canada's 2020 hypertension guidelines for pharmacists: An update.
Can Pharm J (Ott). 2020 Dec 10;154(1):19-25. doi: 10.1177/1715163520975809. eCollection 2021 Jan-Feb.
4
Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, and Assessment of Risk of Pediatric Hypertension.
Can J Cardiol. 2016 May;32(5):589-97. doi: 10.1016/j.cjca.2016.02.075. Epub 2016 Mar 4.
5
Hypertension Canada's 2017 guidelines for diagnosis, risk assessment, prevention and treatment of hypertension in adults for pharmacists: An update.
Can Pharm J (Ott). 2017 Nov 29;151(1):33-42. doi: 10.1177/1715163517743525. eCollection 2018 Jan-Feb.
6
Canada's contribution to global research in cardiovascular diseases.
Can J Cardiol. 2013 Jun;29(6):742-6. doi: 10.1016/j.cjca.2012.09.013. Epub 2012 Dec 6.
7
[Reluctant partner: Canada's relationship with the Pan American Health Organization (PAHO)].
Hist Cienc Saude Manguinhos. 2006 Jul-Sep;13(3):717-32. doi: 10.1590/s0104-59702006000300009.
8
The 2014 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: An update.
Can Pharm J (Ott). 2014 Jul;147(4):203-8. doi: 10.1177/1715163514535341.
9
The 2015 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: An update.
Can Pharm J (Ott). 2015 Jul;148(4):180-6. doi: 10.1177/1715163515586847.
10
The 2012-2013 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: An update.
Can Pharm J (Ott). 2013 May;146(3):146-50. doi: 10.1177/1715163513487476.
引用本文的文献
1
Obesity and risk of hypertension in preadolescent urban school children: insights from Pakistan.
J Health Popul Nutr. 2024 Jun 20;43(1):89. doi: 10.1186/s41043-024-00585-5.
2
Obesity and Risk of Hypertension in Preadolescent Urban School Children: Insights from a Developing Country.
Res Sq. 2024 Apr 12:rs.3.rs-4213965. doi: 10.21203/rs.3.rs-4213965/v1.
3
Evaluation of pharmacist-led telemedicine medication management for hypertension established patients during COVID-19 pandemic: A pilot study.
Front Public Health. 2022 Dec 16;10:1091484. doi: 10.3389/fpubh.2022.1091484. eCollection 2022.
4
Hypertension Canada's 2020 hypertension guidelines for pharmacists: An update.
Can Pharm J (Ott). 2020 Dec 10;154(1):19-25. doi: 10.1177/1715163520975809. eCollection 2021 Jan-Feb.
本文引用的文献
1
Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension.
Can J Cardiol. 2016 May;32(5):569-88. doi: 10.1016/j.cjca.2016.02.066. Epub 2016 Mar 10.
2
The Effectiveness of Pharmacist Interventions on Cardiovascular Risk: The Multicenter Randomized Controlled RxEACH Trial.
J Am Coll Cardiol. 2016 Jun 21;67(24):2846-54. doi: 10.1016/j.jacc.2016.03.528. Epub 2016 Apr 4.
3
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.
Lancet. 2016 Mar 5;387(10022):957-967. doi: 10.1016/S0140-6736(15)01225-8. Epub 2015 Dec 24.
4
Epidemiology of Hypertension in Canada: An Update.
Can J Cardiol. 2016 May;32(5):687-94. doi: 10.1016/j.cjca.2015.07.734. Epub 2015 Aug 15.
5
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.
Lancet. 2016 Jan 30;387(10017):435-43. doi: 10.1016/S0140-6736(15)00805-3. Epub 2015 Nov 7.
6
A Randomized Trial of Intensive versus Standard Blood-Pressure Control.
N Engl J Med. 2015 Nov 26;373(22):2103-16. doi: 10.1056/NEJMoa1511939. Epub 2015 Nov 9.
7
The 2015 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: An update.
Can Pharm J (Ott). 2015 Jul;148(4):180-6. doi: 10.1177/1715163515586847.
8
Thresholds for Diagnosing Hypertension Based on Automated Office Blood Pressure Measurements and Cardiovascular Risk.
Hypertension. 2015 Sep;66(3):489-95. doi: 10.1161/HYPERTENSIONAHA.115.05782. Epub 2015 Jul 27.
9
Automated office blood pressure - being alone and not location is what matters most.
Blood Press Monit. 2015 Aug;20(4):204-8. doi: 10.1097/MBP.0000000000000133.
10
Randomized Trial of the Effect of Pharmacist Prescribing on Improving Blood Pressure in the Community: The Alberta Clinical Trial in Optimizing Hypertension (RxACTION).
Circulation. 2015 Jul 14;132(2):93-100. doi: 10.1161/CIRCULATIONAHA.115.015464. Epub 2015 Jun 10.
Zotero 插件